Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
| Upstream (Parents) |
|---|
| (<<) HNMT → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
| (<<) FABP3 → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
| (<<) HLA-DQB1 → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
| (<<) UBXN8 → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
| (<<) HSD17B6 → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
| (<<) BAMBI → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
| (<<) RP2 → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
| (<<) SF3B3 → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
| (<<) TAX1BP1 → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
| (<<) C19orf59 → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
| Downstream (Children) |
|---|
| LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 → HLA-DQA1 (>>) |
| LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 → HLA-DQB1 (>>) |
